-+ 0.00%
-+ 0.00%
-+ 0.00%

Puma Biotechnology Sees Q4 Sales $67.000M-$70.000M

Benzinga·11/05/2026 21:23:16
Listen to the news
Puma Biotechnology (NASDAQ:PBYI) sees Q4 sales of $67.000 million-$70.000 million.